Recent studies have catalogued more than 10,000 lincRNAs in the human genome [1] [2] [3] [4] and have found that TEs are present in more than two-thirds of mature lincRNA transcripts 5 , thus contributing to the lineage-specific diversification of vertebrate lincRNA repertoires. The functions of families of lincRNAs, defined by TE class, have been linked to diverse biological processes such as imprinting 6 , dosage compensation 7, 8 , regulation of developmental gene expression 7, 8 , chromatin modification 9-11 , and stem cell pluripotency and differentiation in vertebrates 12 . However, functional studies of individual lincRNAs remain challenging, in large part owing to the highly repetitive nature of the sequences and low expression levels, in combination with the absence of high-quality transcript annotation models that accurately define the genomic features of lincRNAs, including transcription start sites, splicing, polyadenylation sites and isoform abundance. As a result, TE-derived lincRNAs have been almost exclusively studied as an aggregate class of repetitive elements [1] [2] [3] [4] [5] [13] [14] [15] [16] [17] . One lincRNA TE class, human endogenous retrovirus-H (HERV-H), has been shown to be required for maintenance of the pluripotent state in human embryonic stem cells (hESCs) 17 . More recently, the activity of specific HERV classes, including HERV-H and HERV-K, has also been linked to human preimplantation embryo development 18, 19 . In addition, a recent study posited that hESC-specific TE-derived lincRNAs may not act as a single functional family, despite the sequence similarity of the component members, but instead may function individually to influence diverse physiological pathways 20 . However, functional data on individual TE-derived lincRNAs are scarce.
Recent studies have catalogued more than 10,000 lincRNAs in the human genome [1] [2] [3] [4] and have found that TEs are present in more than two-thirds of mature lincRNA transcripts 5 , thus contributing to the lineage-specific diversification of vertebrate lincRNA repertoires. The functions of families of lincRNAs, defined by TE class, have been linked to diverse biological processes such as imprinting 6 , dosage compensation 7, 8 , regulation of developmental gene expression 7, 8 , chromatin modification [9] [10] [11] , and stem cell pluripotency and differentiation in vertebrates 12 . However, functional studies of individual lincRNAs remain challenging, in large part owing to the highly repetitive nature of the sequences and low expression levels, in combination with the absence of high-quality transcript annotation models that accurately define the genomic features of lincRNAs, including transcription start sites, splicing, polyadenylation sites and isoform abundance. As a result, TE-derived lincRNAs have been almost exclusively studied as an aggregate class of repetitive elements [1] [2] [3] [4] [5] [13] [14] [15] [16] [17] . One lincRNA TE class, human endogenous retrovirus-H (HERV-H), has been shown to be required for maintenance of the pluripotent state in human embryonic stem cells (hESCs) 17 . More recently, the activity of specific HERV classes, including HERV-H and HERV-K, has also been linked to human preimplantation embryo development 18, 19 . In addition, a recent study posited that hESC-specific TE-derived lincRNAs may not act as a single functional family, despite the sequence similarity of the component members, but instead may function individually to influence diverse physiological pathways 20 . However, functional data on individual TE-derived lincRNAs are scarce.
We recently used a hybrid RNA sequencing technique to identify more than 2,000 new lincRNA transcript isoforms, of which 146 were specifically expressed in pluripotent hESCs 13 . We identified the 23 most abundantly expressed transcripts, confirmed specificity of expression in pluripotent cells and termed the corresponding genomic loci HPAT1-HPAT23 (human pluripotency-associated transcripts . The sequence of one of the HPATs, HPAT5, was also described in 1987 (ref. 21 ). We obtained a consensus sequence of the 856-bp 5′-terminal part of the internal portion of HUERS-P1, an LTR8-containing retrotransposon. Cross-referencing the genomic sequence of HPAT5 with the genomes of seven distinct primate species (baboon, chimpanzee, gibbon, gorilla, marmoset, orangutan and rhesus macaque) suggested that HPAT5 is closely related to a genomic location on chromosome 6 in chimpanzee and gorilla, indicating that HPAT5 was recently introduced into the primate lineage, approximately 5-9 million years ago 22 . Here we show that HPAT1-HPAT23 encode TE-derived lincRNAs; that three HPATs (HPAT2, HPAT3 and HPAT5) may modulate cell fate in human preimplantation
The primate-specific noncoding RNA HPAT5 regulates pluripotency during human preimplantation development and nuclear reprogramming development; and that the molecular mechanism through which HPAT5 functions in hESCs is mediated via let-7.
RESULTS

HPAT1-HPAT23 gene structure
To further probe the identity and function of HPAT1-HPAT23, we began with sequence alignment and found that the majority of the HPAT1-HPAT23 sequences comprise repetitive elements at the genome and transcript levels ( Supplementary Fig. 1a-c) , with these elements accounting for an average of 64.8% (range of 15-99%) of the total lincRNA sequence. Upon closer examination, we found that a large proportion of the repetitive sequences were derived from TEs in four major classes: short interspersed nuclear elements (SINEs), long interspersed nuclear elements (LINEs), long terminal repeat/endogenous retrovirus (LTR/ERV) elements and DNA transposons. Members of the LTR/ERV class represented the largest fraction of genomic sequences (present in all HPATs; average of 44.6%, range of 4.9-97.9%; Supplementary Table 1) . The HERV-H family, as expected, contributed greatly to the sequences of the HPATs (19 of 23 HPATs overlapped with the HERV-H sequence; Supplementary Table 1) , as previously observed for other hESC-specific lincRNAs 14, 17, 23, 24 . Notably, we found that the exons of HPAT genes overlapped with TEs from all four classes, although LTR elements (of the HERV-H subclass) were most common, suggesting that this subclass may contribute most extensively to functional gene features 5 ( Supplementary  Fig. 1d ). In contrast, protein-coding genes that are highly expressed in hESCs such as POU5F1 (also known as OCT4), NANOG and SOX2, showed little to no overlap of gene sequences with TE segments. Thus, we found through sequence alignment that all 23 HPAT genes are derived from TEs. Of these HPAT genes, 13 were derived exclusively from HERV-H elements (100% LTR/ERV sequence coverage), six partially aligned with HERV-H elements (51.7-92.8% sequence coverage) and four were derived from TEs other than HERV-H sequences (Supplementary Table 1 ).
HPAT expression in vivo in human embryos
We next profiled HPAT1-HPAT23 expression in single cells of human blastocysts (Fig. 1a) . Of all the HPAT transcripts, three-HPAT2, HPAT3 and HPAT5-were expressed specifically in the inner cell mass (ICM) and not in trophectoderm, with HPAT5 expressed at the highest levels ( Fig. 1b-d) . No or very low expression was detected for the remaining HPAT transcripts in human blastocysts (data not shown). In addition, we confirmed expression of HPAT3 and HPAT5 in human blastocysts via RNA FISH; note that the prevalence of repetitive sequences in HPAT2 did not allow RNA FISH of this transcript (Supplementary Fig. 1b ). This analysis indicates that both HPAT3 and HPAT5 are expressed predominantly in the ICM (n = 9 blastocysts for HPAT3 and n = 11 blastocysts for HPAT5; Fig. 1e and Supplementary Fig. 2a) , with expression overlapping that of OCT4 protein. Mouse blastocysts (n = 3) provided negative controls for both sets of probes.
To determine whether HPAT2, HPAT3 and HPAT5 function in human preimplantation development, we used short interfering RNAs (siRNAs) to reduce the levels of these transcripts. For this purpose, we injected a single blastomere of an embryo at the two-cell stage with a combination of the siRNAs specifically targeting each of the three HPAT transcripts and tracked development over time with time-lapse imaging and confocal microscopy, with reference to the sister 'control' blastomere. The knockdown efficiency of the siRNAs, in comparison to scrambled siRNA used as a control, was tested before injections, with the results indicating a two-to fivefold reduction in transcript levels (Supplementary Fig. 2b) . Coinjection with fluorophorelabeled dextran facilitated identification of descendent cells in the developing embryo ( Fig. 1f and Supplementary Fig. 2c,d) . We observed that blastomeres deficient for HPAT2, HPAT3 and HPAT5 did not contribute to the ICM (n = 3), whereas cells that originated from blastomeres injected with scrambled siRNA contributed to both the trophectoderm and ICM (n = 3). These data indicate that one or more of the three TE-derived lincRNAs (HPAT2, HPAT3 and HPAT5) likely contribute to formation of the pluripotent ICM. To our knowledge, these data provide the first evidence that lincRNAs may have a fundamental role in vivo in human embryogenesis.
Three HPATs are linked to the core pluripotency network
To probe the biological function of HPATs further, we used an in vitro assay of nuclear reprogramming to produce induced pluripotent stem cells (iPSCs). We began by examining gene expression during the transition from somatic cells to iPSCs. Studies were performed at single-cell resolution to aid in the identification of gene networks and allow reconstruction of network hierarchies during the establishment and maintenance of pluripotency 25 . We collected 864 single cells at different time points of reprogramming, from fibroblasts (day 0) through days 2, 5, 7, 10 and 12 to fully established iPSCs ( Supplementary Fig. 3a,b) . We profiled the expression of 96 transcripts, including HPAT1-HPAT23 and genes expressed in somatic cells and pluripotent stem cells (Supplementary Table 2 ). Assay validation ensured specificity and reproducibility, with 578 single cells and 82 assays passing quality controls to result in a high-quality single-cell data matrix of 47,396 data points that was used for subsequent comprehensive bioinformatic analyses ( Supplementary  Fig. 3c-i) . Results indicated that the expression of genes linked to pluripotency increased over the course of reprogramming, with expression peaking in fully established iPSCs. Conversely, as expected, reprogramming was accompanied by the silencing of fibroblast markers ( Supplementary Fig. 4a,b) . Over the course of reprogramming, three patterns of expression for HPAT transcripts were evident: (i) a gradual increase over the duration of reprogramming, (ii) activation in late stages of reprogramming and (iii) expression exclusive to fully reprogrammed iPSCs ( Fig. 2a and Supplementary Fig. 4c ). Further examination of the data via principal-component analysis (PCA) also demonstrated that two components accounted for the largest proportion (47.5%) of biological variability in the data and, when projected, identified distinct groups of single cells that coincided with the time point of collection. Unsupervised clustering illustrated in a heat map confirmed these observations ( Supplementary  Fig. 4d,e) . Notably, to determine whether expression was simply a consequence of transcriptionally permissive chromatin during periods of transition from one cell fate to another, we examined whether HPAT transcripts were expressed in the transition from fibroblasts to induced neurons. We observed no expression of HPATs in the derivation of induced neurons from fibroblasts ( Supplementary Fig. 4f , exemplified by HPAT2).
We extended our analysis of HPAT gene expression in the context of the establishment of pluripotency in single cells via bicluster and correlation analysis (Fig. 2b,c, Supplementary Fig. 4g , Supplementary Table 3 and Supplementary Note) and derived a Bayesian network based on all pluripotency markers and HPATs, across all single cells (Fig. 2d) . In agreement with previous reports 26 , our Bayesian network identified (i) a triangle consisting of POU5F1, NANOG and SOX2, known to be the core pluripotency regulators [27] [28] [29] , and (ii) the close association of SALL4 with the core pluripotency network 30, 31 . Notably, we observed that the three new lincRNAs (HPAT2, HPAT3
A r t i c l e s and HPAT5) that emerged in our previous bicluster and correlation analysis, as well as preimplantation embryo studies, were closely linked to the core regulatory network of pluripotency and directly associated with POU5F1, SOX2, SALL4 and NANOG (Fig. 2d) . Note that HPAT2 and HPAT3 both map to chromosome 2 and are derived from HERV-H elements; HPAT5 maps to chromosome 6 and comprises SINE and HUERS-P1 repeat elements (Supplementary Fig. 5d ).
HPATs modulate reprogramming and hESC differentiation
To test whether HPAT2, HPAT3 and HPAT5 are required for nuclear reprogramming in induced pluripotency, we transiently knocked down their expression simultaneously over the course of mRNA-based reprogramming (Fig. 3a) . Transient knockdown with siRNAs ( Supplementary Fig. 5a (efficiencies) and Supplementary Table 4) inhibited reprogramming and resulted in formation of fewer TRA-1-60-positive cells and alkaline phosphatase-positive colonies, both markers for pluripotency, in comparison to control cells ( Fig. 3b-d) . Titration of siRNA molecules resulted in more pronounced phenotypes (Fig. 3e,f) . To determine the effects of single HPATs, we reduced the levels of HPAT2, HPAT3 and HPAT5 transcripts individually and evaluated reprogramming efficiencies. Reduced expression of each individual HPAT appeared to negatively affect nuclear reprogramming; however, reduced expression of HPAT5 alone resulted in a statistically significant reduction in the number of alkaline phosphatase-positive colonies (Fig. 3h,i) . To ensure reproducibility, experiments were performed twice with three replicates; we also ensured that the observed results were not a consequence of different cell proliferation rates (Fig. 3g) .
Concurrently, we overexpressed all three HPATs (days 0 and 3; Supplementary Fig. 5b ) and observed reciprocal phenotypes with elevated reprogramming efficiencies (Fig. 3a-f) . We also reprogrammed BJ fibroblasts by inclusion of all three HPATs at different molar ratios in combination with POU5F1 mRNA. Note that transfection with POU5F1 mRNA alone never resulted in reprogramming. In contrast, although the majority of trials resulted in no reprogramming to pluripotency, when POU5F1 was expressed with HPAT2, HPAT3 and HPAT5 at a molar ratio of 3:1:1:3 ( Fig. 3j) , alkaline phosphatase-positive clones were successfully derived. 
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On the basis of the data outlined above, we suspected that the HPAT genes might be under the transcriptional control of key transcription factors linked to pluripotency. Thus, we generated NANOG chromatin immunoprecipitation and sequencing (ChIP-seq) data from hESCs (H9) using 100-bp paired-end reads. NANOG is a transcription factor that occupies single-copy loci, as well as TEs including the ERV1 repeat family and LTR7 sequences in pluripotent stem cells 14, 24 . We observed that HPAT2, HPAT3 and HPAT5 (and all other HPAT genes) were specifically bound by NANOG ( Supplementary Fig. 5c,d and Supplementary Table 5) . We then compared our data set with the NANOG ChIP-seq data set generated by Kunarso et al. 32 and observed extensive overlap (72%), indicating that the data sets are very comparable. Indeed, almost every single HPAT gene promoter region was also found to be bound by NANOG in the Kunarso et al. data set (data not shown). Moreover, exogenous expression of NANOG activated HPAT2, HPAT3 and HPAT5 expression in fibroblasts in a methylation-dependent manner (Fig. 3k) . Collectively, these results indicate that HPAT2, HPAT3 and HPAT5 expression is regulated by NANOG and can contribute directly to reprogramming and acquisition of pluripotency. HPAT5, relative to HPAT2 and 
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HPAT3, appeared to have more pronounced effects and had a unique sequence derived from a previously uncharacterized ERV in pluripotent stem cells. Thus, we focused further efforts on the HPAT5 gene using a series of complementary functional assays.
To determine whether HPAT5 modulates differentiation, we generated an H1 hESC line that stably overexpressed HPAT5 (HPAT5-OE) under the control of the EEF1A1 promoter ( Supplementary Fig. 5e,f) . Under self-renewal conditions, HPAT5-OE cells displayed normal pluripotent stem cell morphology and a high level of expression of HPAT5 mRNA relative to the control line. Upon differentiation (forced via the removal of basal fibroblast growth factor (bFGF) and downregulation of POU5F1 expression) (Fig. 4a) , ectopic overexpression of HPAT5 suppressed hESC differentiation, as indicated by increased and persistent expression of the pluripotency markers POU5F1, NANOG and SOX2 (Fig. 4c) at days 3 and 6 after differentiation, in combination with delayed upregulation of genes indicative of differentiation of all three germ layers ( Supplementary Fig. 5g ). Conversely, control mCherry-overexpressing H1 hESCs readily differentiated under the same conditions and adopted a somatic cell-like morphology 3 d after transfection ( Fig. 4b and Supplementary Fig. 5e ,f).
HPAT5 binds to members of the microRNA processing machinery
Genes for lincRNAs have been shown to be involved in epigenetic regulation, by recruiting chromatin-remodeling complexes 33, 34 . To determine whether the HPAT5 gene might function through interactions with chromatin-remodeling complexes or other RNA-binding proteins, we used protein microarray assays to globally screen interactions between HPAT5 and candidate proteins in vitro 35 . This analysis yielded a list of candidates that bound in vitro to HPAT5 (Supplementary Fig. 6a-d, Supplementary Table 6 and npg Supplementary Note). TARBP2, a subunit of the RNA-induced silencing complex (RISC) that has a major role in the microRNA (miRNA) processing pathway 36 , showed the most significant enrichment in binding. AGO2, a second subunit of RISC, was also among the proteins most significantly bound to HPAT5. This result was surprising, as it is commonly known that miRNAs are required to guide RISC to target RNAs, despite recent reports that have consistently observed AGO2-RNA associations independent of miRNAs 37 .
We included HPAT2 and HPAT3 as controls and validated binding with proteins previously described, such as OCT4, to interact with HERV-H-containing sequences (Supplementary Fig. 6e) (ref. 17) . In light of these results, we hypothesized that HPAT5 exerts post-transcriptional regulation of gene expression, possibly by binding to specific miRNAs through the miRNA-loading complex. To test this hypothesis, we used a bioinformatic approach (see URLs) aimed at predicting miRNA response elements (MREs) in the HPAT5 transcript. We included HPAT2 and HPAT3 as controls in our analysis to demonstrate differences in predicted binding partners from HPAT5. linc-ROR was used as an additional control, as it harbors HERV-H-derived sequences at its 5′ end, as do HPAT2 and HPAT3 (Supplementary Table 7 ). Our analysis showed that, whereas HPAT2 and HPAT3 were predicted to bind similar miRNAs, the list of miRNA potentially bound by HPAT5 was substantially different. Indeed, one entire miRNA family-the let-7 family-was predicted to bind to exon 2 of HPAT5 within an Alu element, a TE subclass of SINEs, but not to HPAT2 or HPAT3 (Supplementary Fig. 7a ). This miRNA family has previously been shown to function in modulating hESC pluripotency and reprogramming, and its expression has 
HPAT5 modulates let-7 expression
To validate that HPAT5 is indeed targeted in vivo by let-7, we constructed luciferase reporters encoding full-length HPAT5 in the 3′UTR of the luciferase gene (Fig. 4d) .
Reporters were cotransfected into HEK293 cells with two miRNA mimics (Hs-let-7a and Hs-let-7d). HPAT2, HPAT3 and linc-ROR were used as negative controls. The Hs-let-7a and Hs-let-7d mimics significantly reduced luciferase activity in comparison to scrambled miRNA for the HPAT5 reporter (Fig. 4e) . No differences were observed in negative controls. Further, to test the specificity of binding of the Hs-let-7a and Hs-let-7d mimics to predicted target sites, we deleted both MREs in HPAT5 and constructed a mutant luciferase reporter (HPAT5-mutant) to measure its activity in HEK293 cells. Whereas the wild-type reporter showed significantly decreased luciferase activity when cotransfected with the Hs-let-7a and Hs-let-7d mimics, the mutant reporter was refractory to Hs-let-7a-and Hs-let7d-driven reporter inhibition (the activity was comparable to that of control cells transfected with scrambled miRNA or no miRNA) (Fig. 4f) . We expanded our analysis by introducing two different point mutations in the seed sequence (base pairs 4 and 6) of the Hs-let-7a and Hs-let-7d mimics and with two additional mutant reporters that compensated for the mutations in HPAT5 (Fig. 4g,h ), confirming our previous results. To further test whether, in addition to binding to mature let-7 miRNAs, HPAT5 might interfere with let-7 maturation (conversion from pri-miRNA to mature miRNA), we measured the expression levels of pre-let-7 miRNA in differentiated fibroblasts that transiently overexpressed HPAT5. Endogenous mature let-7 levels but not prelet-7 levels were significantly downregulated 48 h after exogenous HPAT5 overexpression, indicating that HPAT5 does not suppress the transcription of let-7 or inhibit the maturation of pre-let-7 into let-7 (Supplementary Fig. 7b ). In contrast, LIN28A overexpression (used as a positive control) resulted in significant downregulation of pre-let-7 expression, which leads to decreased mature let-7 levels, consistent with the literature 42, 43 .
Collectively, our results demonstrate that let-7 binds specifically to complementary sequences on HPAT5 and that point mutations within the seed sequence of let-7 can abolish this interaction. Further, we demonstrated that overexpression of HPAT5 in hESCs delayed induced differentiation (Fig. 4a-c) and that HPAT5 is functionally linked to the differentiation by interaction with let-7. To probe functional interaction further, we knocked out the endogenous genomic HPAT5 locus in pluripotent stem cells (HPAT5-KO) using CRISPR/ Cas9 (Supplementary Fig. 7c-e) . Analysis of HPAT5-null cells showed increased let-7 levels relative to wild-type cells ( Supplementary  Fig. 7f ), although these levels were not sufficient to induce spontaneous hESC differentiation. These results are consistent with studies in wild-type mouse ESCs in which additional mechanisms exist to ensure protection of the pluripotent state by inhibiting let-7 activity or that of other stem cell-specific miRNAs 38, 44 .
To test whether HPAT5 ablation has a significant effect on reprogramming efficiencies (as indicated by our experiments with siRNAs in Fig. 3h) , we differentiated HPAT5-KO hESCs into fibroblasts 45 and reprogrammed them back into iPSCs using episomal vectors encoding the Yamanaka factors (Supplementary Fig. 7g ). HPAT5-KO secondary fibroblasts reprogrammed with lower efficiencies than wild-type secondary fibroblasts, as indicated by lower percentages of alkaline phosphatase-and TRA-1-81-positive cells at day 24 after the initiation of reprogramming (Supplementary Fig. 7h ). In addition, we assessed endogenous HPAT5 and let-7 levels in cells that were transitioning between the fibroblast and iPSC states ( Supplementary  Fig. 7i ). HPAT5-KO cells had significantly (P = 0.0191) higher let-7 levels at day 10 of reprogramming than wild-type controls. However, let-7 levels were, similar to in wild-type cells, significantly lower in HPAT5-depleted cells in comparison to the originating fibroblasts, indicating that additional mechanisms regulate endogenous let-7 expression during the acquisition of pluripotency (for example, expression of LIN28; ref. 43 ). 
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Our data suggest that HPAT5 might be modulating the balance between pluripotency and differentiation by counteracting let-7 activity when let-7 is expressed at very high levels (for example, in somatic cells). To test this hypothesis, we overexpressed let-7 in HPAT5-KO and wild-type cells and examined gene expression changes 48 h after treatment. Exogenous overexpression of let-7 triggered differentiation in HPAT5-KO cells relative to wild-type cells, as determined by microarray analysis and examination of morphological changes (Fig. 5a and Supplementary Table 8) .
To rescue the effects of let-7-mediated differentiation in HPAT5-KO cells, we transfected cells with an overexpression vector for wildtype HPAT5. We also overexpressed a mutant HPAT5 transcript that lacked the predicted let-7-binding sites to test for specificity. Whereas overexpression of wild-type HPAT5 provided partial rescue of let-7-mediated differentiation in HPAT5-KO lines, the HPAT5 mutant did not do so but instead led to changes in the transcriptome similar to those observed in cells that overexpressed let-7 alone ( Supplementary  Fig. 8a and Supplementary Table 8) . To determine whether differentiation in HPAT5-KO lines was triggered by downregulation of let-7 targets, we used cWords, a tool that identified enrichment of miRNA seed sequences among the entire list of ranked differentially expressed genes. Among the top-ranked seed sequences that were shared by the most significantly downregulated genes in HPAT5-KO cells was the let-7 seed (TACCTC) (Supplementary Table 5b) . Similarly, the let-7 seed sequence was significantly enriched in HPAT5-KO cells that failed to rescue endogenous HPAT5 depletion (Supplementary Fig. 8b-d) .
In contrast, HPAT5-KO cells in which wild-type HPAT5 was rescued were not enriched for downregulated genes that shared a let-7 seed sequence, indicating that exogenous HPAT5 successfully sequestered overexpressed let-7 to prevent it from downregulating its targets.
To further probe the regulatory role of HPAT5 in the expression of let-7 in hESCs, we overexpressed and knocked down HPAT5 in hESCs and assessed mature let-7 miRNA levels at 48 h after transfection. To control for non-specific binding, we again used the overexpression vector for mutant HPAT5. The expression levels of both mature let-7 miRNAs were inversely associated with the expression levels of HPAT5 (Fig. 5c) . Specifically, we observed the most significant change in Hs-let-7d expression upon knockdown of HPAT5. In contrast, mutant HPAT5 did not have the same effect, suggesting that HPAT5 negatively regulates let-7 expression and activity through specific binding. In addition, when we overexpressed let-7 in hESCs, HPAT5 levels were downregulated in comparison to those in control samples (Supplementary Fig. 8e ). Given that miRNA-lincRNA target pairs can be purified by immunoprecipitation of the RISC component AGO2 (ref. 46) , we tested whether AGO2 would coprecipitate with HPAT5. RNA immunoprecipitation (RIP) followed by quantitative PCR (qPCR) confirmed the in vivo interaction between HPAT5 and AGO2 in the presence of let-7 in hESCs, in contrast to GAPDH ( Fig. 5d and Supplementary Fig. 8f) . Collectively, these results indicate that mature let-7 is able to directly bind and guide RISC to its target, HPAT5 (Fig. 5) .
DISCUSSION
Recent data have linked one entire class of TE-derived lincRNAs (HERV-H) to a naive pluripotent hESC state in vitro that resembles pluripotent cells of the human ICM 16 . Yet, to our knowledge, this study is the first to probe the biological relevance of three individual TE-derived lincRNAs during human embryo development in vivo and to use CRISPR-mediated gene editing technology to investigate the mechanism of action of a single lincRNA in knockout human stem cells in vitro.
The importance of crosstalk between miRNAs and lincRNAs in the regulation of pluripotency in hESCs has been documented in several studies 20, 38 . Here we provide data that support crosstalk between let-7 and HPAT5. We observed that let-7 binding occurs within an Alu element in the second exon of HPAT5 (Supplementary Fig. 7a) . The acquisition of a single base pair within this Alu element in HPAT5 has generated a let-7 seed sequence, likely conferring specificity to HPAT5. Other Alu elements, which have expanded tremendously in primate genomes, have an important role in human embryonic development and, more importantly, have been described to function in DNA binding and mRNA recognition when embedded in lincRNAs [47] [48] [49] [50] . Indeed, a recent study has shown that several human miRNAs and miRNA target sites are, in fact, derived from L1, Alu and MIR elements 40, 51 .
More recently, the activity of specific classes of retrovirus-derived lincRNAs has been linked to human preimplantation embryo development. LTR-driven expression of specific HERV families has been described in a stage-specific context during early human embryo development 18 . Two specific HERV families (HERV-H and HERV-K) have also been linked to human preimplantation development. Grow et al. described LTR element-driven reactivation of HERV-K, which, unlike most other HERVs, has retained multiple copies of intact ORFs that encode retroviral proteins 19 . In contrast, HERV-H expression may have regulatory roles in establishing and/or maintaining pluripotency, a hallmark of pluripotent epiblast cells in blastocyst-stage embryos 16 . These findings, together with our results, demonstrate that different HERV elements have distinct roles in regulating fundamental biological processes, including the acquisition of pluripotency in vivo during embryogenesis. Dissecting the role of each single HERV element may be of paramount importance to understanding the specifics of human development. We anticipate that direct genetic dissection via genome editing, as demonstrated here, may find that many cell fate decisions, including those of human pre-and postimplantation development, are modulated by complex regulatory mechanisms that employ 'recycled' retroviral sequences that were introduced and modified during the course of evolution to confer human-specific dynamics to development.
URLs. Bioinformatic pipeline, http://regrna2.mbc.nctu.edu.tw/; Bioresearch Technologies, http://www.biosearchtech.com/; Massachusetts Institute of Technology CRISPR design tool, http://crispr. mit.edu/.
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Methods and any associated references are available in the online version of the paper.
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ArrayExpress, E-MTAB-2994; Gene Expression Omnibus (GEO), GSE73725. ChIP-Seq data on NANOG in H9 are deposited in the Gene Expression Omnibus (GEO) database. Microarray data on H9 hESCs are deposited in the ArrayExpress database. 
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ONLINE METHODS
Cells. BJ human fibroblast cells (passage 6) were established from normal fetal foreskin, purchased from Stemgent and used for nuclear reprogramming toward iPSCs. Cells were tested for mycoplasma prior to use for experiments.
Cell culture. BJ fibroblast cells were cultured on plates coated with 0.2% gelatin (Sigma) in DMEM-FBS (DMEM + GlutaMAX (DMEM) supplemented with 10% FBS, 100 U/ml penicillin and 100 µg/ml streptomycin). Fibroblasts were maintained in culture by changing the medium every 3 d and passaging cells at a 1:3 dilution when they were 80-90% confluent. hESCs (H9 and H1) and derived iPSCs were cultured on plates precoated with growth factor reduced Matrigel (BD Biosciences) in basal mTeSR1 medium (Stemcell Technologies) supplemented with 5× mTeSR1 supplement (Stemcell Technologies). Cells were maintained in culture by changing the medium daily and enzymatically passaging cells at a 1:2 to 1:5 dilution with prewarmed Accutase (Innovative Cell Technologies). Differentiated cells were removed and/or cleaned under a laminar flow dissection hood.
All cultures were maintained at 37 °C and 5% CO 2 . BJ fibroblasts were frozen in 90% FBS (Gibco, Life Technologies) and 10% DMSO (SigmaAldrich). hESCs and iPSCs were frozen in Bambanker (Wako Chemicals). Tissue culture reagents and chemicals were purchased from Life Technologies, Sigma-Aldrich, Becton Dickinson and Company (BD) and Fisher Scientific unless otherwise stated.
Microarray analysis. Total mRNA was isolated from hESCs using the RNeasy kit (Qiagen). The quality of the total RNA was confirmed using an Agilent 2100 Bioanalyzer. Samples were sent to the Pan Facility at Stanford University for further processing. Biotinylated cRNA was prepared according to the standard Affymetrix protocol from 6 µg of total RNA (GeneChip Whole-Transcript Sense Target-Labeling Assay, 701880 Rev.5, Affymetrix). The samples were then hybridized to the Human Gene 2.0 ST array. Probe arrays were washed and scanned with the Hewlett-Packard GeneArray Scanner G2500A. Raw data files were created by Command Console, the Affymetrix operating software program. The Affymetrix Expression Console Program was used to examine the Affymetrix Gene Array quality control factors for all samples in a project. Global scaling was used as the normalization method (RMA). Enrichment analysis was performed with cWords.
Statistical analysis.
For single-cell analysis, individual cells were considered as biological replicates (n = 578). Calculated primer efficiencies were normally distributed, as determined by the Shapiro-Wilk test. For normally distributed data, we used the two-tailed Student's t test for significance calculations. Nonparametric statistical approaches were applied for data not following a normal distribution. Specifically, we chose the Kurskal-Wallis test for independent and unequally sized sample calculations. Statistical significance was set to P < 0.05 for gene expression analysis (n > 3) and the Plaid and CC bicluster algorithm, respectively. The Xmotif bicluster algorithm only resulted in bicluster formation with P < 0.01. Only Bayesian network connections with P < 0.05 are shown. Correlation analysis found only significant correlations with P < 0.05. For TRA-1-60-and alkaline phosphatase-positive colony count, sample counts were normalized to the total number of iPSC colonies within one experiment to decrease variability between experiments. Resulting values (for each experiment) were subjected to two-tailed Student's t test. Error bars represent standard deviation in all tests of statistical significance.
Assay performance validation. Primers were designed to span introns to avoid the amplification of possible contaminating genomic DNA. Each primer pair was tested before use for single-cell gene expression analysis for efficiency, sensitivity and specificity as well as to determine the expected melting temperature (T m ) for the specific amplicon for each assay. We used cDNA prepared from bulk total RNA extracted from BJ fibroblasts, hESCs (H1) and iPSCs (BJ.iPSCs). Preamplification was performed with 20 ng of total RNA, 50 nM of each primer pair and 1× TaqMan PreAmp Master Mix (Applied Biosystems) in a 20-µl total volume. The thermal cycling protocol comprised incubation at 95 °C for 10 min; 14 cycles of 95 °C for 5 s and 60 °C for 4 min; and holding at 4 °C. Samples were treated with Exonuclease I (NEB) at 37 °C for 30 min, and the reaction was inactivated by heating at 80 °C for 15 min. cDNA was diluted with DNA suspension buffer (Teknova) to a total volume of 100 µl. A 1:2 dilution series was prepared by mixing 30 µl of each cDNA sample with 60 µl of DNA suspension buffer. The diluted cDNA sample was subsequently diluted further, down to a 14× dilution of the original sample. The 15 cDNA samples, including a no-template control (DNA suspension buffer), were analyzed by qPCR using a 96.96 Dynamic Array Integrated Fluidic Circuit (IFC) and the BioMark HD (Fluidigm) according to the manufacturers' instructions. Each diluted sample was loaded in six technical replicates to determine the lower limit of technical noise of the instrument. Only sample-assay combinations with specific amplification were used for standard curve calculations of log 10 -transformed sample dilution versus average C t value. For each assay, efficiency was estimated from the slope of the standard curve using efficiency (E) = 10 −1/slope − 1. Linear regression analysis depicted a precise quantitative response to the dilution series for 88 of 96 assays as R 2 values were between 0.97 and 0.99 (Supplementary Fig. 3c-e) ; thus, we excluded the eight assays with R 2 <0.97. Using the primer efficiency distribution histogram, we calculated an average primer efficiency of 1.02 (102%) with s.d. = 0.06 (Supplementary Fig. 3d ).
Single-cell quantitative PCR. We used the C1 Single-Cell Auto Prep System (Fluidigm) for single-cell capture and preamplification according to the manufacturer's instructions (protocol 100-4904). Briefly, we prepared a pool of all x primers (500 nM). We then prepared a lysis final mix, a reverse-transcriptase (RT) final mix and a preamplification (PreAmp) final mix and stored them on ice. Next, the C1 IFC chip for medium-size single cells (10 to 17 µm in diameter; barcode 1782x) was primed: 200 µl each of C1 collection reagent, preloading reagent, blocking reagent and wash buffer were loaded onto the chip, the chip was placed into the C1 Single-Cell Auto Prep System and the script 'Prime (1782x)' was run. Priming lasted 20 min, and cells were prepared in the meantime as follows. For days 0-7, when cells were still homogeneous in culture, cells were treated with Accutase (Innovative Cell Technologies) to generate a single-cell suspension, washed once and resuspended in Pluriton medium at a concentration of 250 × 10 3 cells/ml. For days 7-12 and iPSCs, colony-like structures were manually isolated and treated with Accutase, washed once and resuspended in Pluriton medium at a concentration of 250 × 10 3 cells/ml (see Supplementary Fig. 3b for phase-contrast images). Then, 12 µl of single-cell suspension was mixed with 8 µl of C1 Cell Suspension Reagent (Fluidigm). After priming, the blocking and priming solutions were removed and 10 µl of cell mix was loaded onto the C1 chip. The C1 chip was placed back into the instrument, and the script 'Cell Load (1782x)' was run. After cell capturing, the C1 chip was removed and single-cell capturing was evaluated on a microscope (Supplementary Fig. 3f ). Empty capture sites were noted, and the C1 chip was loaded with collection reagent, 7 µl of lysis final mix, 7 µl of RT final mix and 24 µl of PreAmp final mix. The chip was placed back into the instrument, and the script 'PreAmp (1782x)' was run with the following settings: reverse transcription, 25 °C (600 s) and 42 °C (3,600 s); preamplification, 95 °C (600 s), 18 cycles of (95 °C (15 s) and 60 °C (240 s)) and 4 °C (hold). After preamplification, the C1 chip was removed from the instrument and 3 µl of cDNA (for each single cell) was isolated and diluted in 25 µl of DNA suspension buffer (Fluidigm). Preamplified samples were then subsequently used on the BioMark HD using the protocol 100-3488 and starting with the preparation of sample and assay mix (see "RNA isolation and gene expression analysis of bulk samples with quantitative PCR").
Determining limit-of-detection values. Because of the lognormal distribution described by Bengtsson et al. 53 and others, single-cell data are best viewed as expression level above detection limit on a log scale. For qPCR data, we determined the log base 2 and defined log 2 (expression) = LOD C t − C t raw (of gene), where LOD is the limit of detection. We used bulk RNA and the dilution series of generated cDNA samples to calculate LOD Ct as follows. Mean C t values and s.d. for each assay (six replicates) were calculated for all serial dilutions. Average C t values with s.d. >1 determined the threshold that was assigned to the LOD for each assay. We finally calculated the median of all LOD C t values across all assays to determine a universal LOD C t score of 25, which was used throughout this study.
npg Quality assessment and normalization of single-cell expression values. Melting curves were analyzed, and false positive signals were excluded (Supplementary Fig. 3g ). Chip-to-chip variation was assessed with three IFCs (fibroblasts, fibroblasts transfected with GFP for 2 d and fibroblasts transfected with GFP for 5 d) to identify assays that significantly change across different IFC chips (Supplementary Fig. 3h ). We excluded six assays (DPPA4, HDAC3, HPAT11, HPAT13, INO80C and PRMT5) for subsequent analysis because they did not correlate within an acceptable range between the three IFCs. The remaining 82 assays (Supplementary Table 2 ) led to only small observed variations in gene expression changes across all three IFCs, indicating their robustness across chip-to-chip variation as well as GFP versus non-transfected single cells and were used for subsequent analysis. Then, raw C t values were converted to expression levels using log 2 (expression) = LOD C t − C t raw (of gene) with LOD Ct = 25. Values with log 2 (expression) <0 were excluded. Genes expressed in fewer than 5% of single cells were eliminated as well. Single cells with log 2 (expression) values lower than 3 s.d. of an assay across all cells were labeled apoptotic and were excluded; 192 cells (two IFCs with GFP control) were removed from further analysis and 94 cells across all seven remaining IFCs were eliminated owing to the above-mentioned reasons, resulting in 578 cells. We normalized such that each cell had the same median log 2 (expression) value across all genes detected in that cell. This ensured that the normalization factor included data from all genes in the study. For this study, we generated a highquality data matrix of 578 genes across 82 assays, resulting in 47,396 single-cell expression values that was used for data analysis (Supplementary Fig. 3i ).
Alkaline phosphatase and TRA-1-60 staining. Alkaline phosphatase staining was performed using Vector Red Alkaline Phosphatase Substrate Kit I (Vector Laboratories) following the manufacturer's instructions.
StainAlive DyLight 488 anti-Human TRA-1-60 antibody (Stemgent) was diluted in fresh cell culture medium to a final concentration of 5 µg/ml. Old medium was aspirated and replaced with medium containing diluted antibodies. Cells were incubated for 30 min at 37 °C and 5% CO 2 . The medium with primary antibody was aspirated, and cells were washed gently twice with cell culture medium. Fresh cell culture medium was added, and cells were examined under a fluorescent microscope using the appropriate filters. Cells were kept in culture after examination. Representative images (n > 3) were acquired with the same microscope settings (gain, exposure and fluorescence excitation), and fluorescence intensity (emission) was measured with ImageJ and calculated against TRA-1-60-negative cells.
Derivation of mRNA-induced pluripotent stem cells. BJ fibroblasts were seeded at 1-4 × 10 4 cells per well of a six-well plate on wells coated with growth factor reduced Matrigel and cultured in Pluriton basal medium. After 24 h, Pluriton basal medium was replaced with conditioned Pluriton media from NuFF cells (human fibroblasts, GlobalStem) (Stemgent) supplemented with Pluriton supplement (Stemgent) and B18R (200 ng/ml; eBioscience). Cells were transferred to a low-oxygen environment (5%) for higher reprogramming efficiency before the first transfection. After 2 h of equilibration in low-oxygen conditions, mRNA cocktail containing OSKM factors (OCT4, SOX2, KLF4 and MYC) was transfected into cells, and transfection was repeated every 24 h until colony formation was observed, around day 12-14. Incubation of mRNA and transfection mix with cells was carried out for 4 h.
Primary iPSCs appeared around day 14 and were handpicked onto fresh culture dishes coated with Matrigel; the medium was replaced with mTeSR1 supplemented with 5× mTeSR1 supplement. Established iPSC lines were cultured under 20% oxygen conditions and were subjected to single-cell gene expression analysis. The pluripotency of iPSCs was assessed by teratoma formation (Supplementary Fig. 3a ). Reprogramming efficiencies with our optimized feeder-free mRNA-based protocol ranged between 4-6% on the basis of initial cell seeding numbers and fully developed primary colonies.
Functional characterization of HPAT2, HPAT3 and HPAT5 during nuclear reprogramming was performed in replicate. Combined knockdown or overexpression of HPAT2, HPAT3 and HPAT5 was performed twice. Nuclear reprogramming with single HPATs was performed twice. Reprogramming with OCT4 and HPAT2, HPAT3 and HPAT5 was performed once with different molar ratios of all four factors. The molar ratio of 3:1:1:3 for OCT4, HPAT2, HPAT3 and HPAT5 was repeated for confirmation. Statistical significance between TRA-1-60-positive cell counts was assessed by fluorescence detection with ImageJ. Three representative areas for each experimental group were used to analyze fluorescence intensities, and Student's t test was applied. Statistical significance was measured in a similar fashion for iPSC colony counts on the basis of positive staining for alkaline phosphatase and cell number counts.
In vitro differentiation. Neuronal differentiation. Differentiation was initiated from fibroblasts that were directly converted into induced neuronal cells as previously described 54 (Supplementary Fig. 4d ).
RNA isolation and gene expression analysis of bulk samples with quantitative PCR. Gene expression analysis was performed using a microfluidic platform (Fluidigm) following the manufacturer's protocol Single-Cell Gene Expression Using EvaGreen DNA Binding Dye (protocol 100-3488), with some modifications adjusted for bulk samples. Briefly, CellsDirect 2× Reaction Mix (Life Technologies), SuperScript III RT Platinum Taq Mix (Invitrogen), 4× Primer Mix (200 nM) and DNA suspension buffer (Teknova) were added to a total volume of 9 µl. Cells in bulk were collected, washed and counted; the cell suspension was adjusted to a concentration of 50,000-100,000 cells/ml. One microliter of cell suspension was added to each reaction, and the following thermal cycling protocol was set: reverse transcription, 50 °C for 15 min; inactivation of reverse transcriptase/activation of Taq, 95 °C for 2 min for 18 cycles, 95 °C for 15 s and 60 °C for 4 min, 4 °C for infinity. ExoSAP-IT treatment removed unused material and was performed at 37 °C for 30 min (digestion) and 80 °C for 15 min (inactivation). The reaction was diluted 1:5 in DNA suspension buffer and stored at −20 °C or immediately used for sample pre-mix. Sample pre-mix, sample and assay mix were prepared according to the manufacture's instructions (Fluidigm). Dynamic Arrays IFCs (96.96 or 48.48) were primed with control line fluid, and the chip was loaded with assay and sample mixes using the HX IFC controller (Fluidigm). RT-PCR was performed on the BioMark HD (Fluidigm) with the following two-step fast cycling protocol (EvaGreen): 95 °C (2 min) followed by 40 cycles of 95 °C (5 s), 60 °C (20 s) and melting curve generation.
Teratoma formation. The pluripotency of derived iPSCs was evaluated with teratoma formation assays. Cells (one well of a 12-well plate) were collected in 30 µl of culture medium and injected into the kidney capsule of SCID mice (adult (10 weeks), female; Stanford Assurance Number A3213-01, protocol number 16146). After 3-4 weeks, teratomas were dissected and fixed overnight in 4% paraformaldehyde diluted in PBS.
Fixed samples were sent to AML Laboratories for paraffin embedding, sectioning and staining with hematoxylin and eosin. Sections were then examined for the presence of tissue representatives of all three germ layers.
ChIP-seq. ChIP assays were performed from approximately 1 × 10 7 cells per experiment, according to a previously described protocol with slight modifications 27 . Briefly, cells were cross-linked with 1% formaldehyde for 10 min at room temperature, and formaldehyde was quenched by the addition of glycine to a final concentration of 0.125 M. Chromatin was sonicated to an average size of 0.5-2 kb, using a Bioruptor (Diagenode). Protein G dynal beads (50-75 µl; Invitrogen) were used to capture 3-5 µg of antibody in phosphate citrate buffer, pH 5.0 (2.4 mM citric acid, 5.16 mM Na 2 HPO 4 ) for 30 min at 27 °C. Antibody-bead complexes were rinsed two times with PBS and added to sonicated chromatin; samples were rotated at 4 °C overnight. Ten percent of chromatin was reserved as 'input' DNA. Magnetic beads were washed and chromatin was eluted, followed by reversal of the cross-linking and DNA purification. Resultant ChIP DNA was dissolved in TE buffer. Results were verified with qPCR of seven selected regions ( Supplementary Fig. 5c and Supplementary Table 5 
